Showing 1 posts of 1 posts found.
Roche’s Genentech unit has agreed to pay $120 million upfront as part of a research and licensing deal with California-based …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO